Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT04727151
Title TAC T-cells for the Treatment of HER2-positive Solid Tumors (TACTIC-2)
Acronym TACTIC-2
Recruitment Terminated
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors Triumvira Immunologics, Inc.
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA | CAN


No variant requirements are available.